通过带有柏柏林的粘膜粘合剂表面修饰脂质体针对帕金森病的创新方法:一项多方面的研究
Hisham A Nematalla1,2, Mona Elharoun1, Mohammad M Abd-Alhaseeb1,3
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhour University, Damanhour, 22511, Egypt.
BMC pharmacology & toxicology
|December 9, 2025
概括
装载着柏柏林的桑装饰的纳米脂质体 (BER 基因组) 显示出治疗帕金森病 (PD) 的前景. 在动物模型中,鼻内输送增强了脑透和改善了运动功能.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 帕金森病 (PD) 影响全球数以百万计的人,其特点是和肌肉硬.
- 目前的治疗方法提供症状缓解,但不能阻止神经退行性进展.
研究的目的:
- 通过使用鼻至大脑通路通过粘粘性纳米脂质体 (细胞体) 输送的柏柏林 (BER) 的治疗潜力进行评估.
- 为了提高柏柏林的生物可用性和血脑屏障的透,以改善帕金森病的治疗.
主要方法:
- 开发和描述包装柏柏林 (BER) 的基托装饰脂质体 (基托体).
- 在体外分析颗粒大小,泽塔潜力,封装效率和药物释放.
- 在体内研究使用罗诺诱导的帕金森病老鼠模型,评估运动功能,生物标志物和组织病理学.
主要成果:
- 优化的BER基因组体表现出良好的特征,包括持续释放.
- 在PD大鼠模型中,鼻内注射显著改善了运动功能和协调.
- 贝尔基因组减少了α-synuclein,增加了多巴胺水平,并减轻了氧化应激 (NF-κB,Nrf2).
- 组织学分析显示,神经元退化减少和利维体形成.
结论:
- 带有BER的基因细胞体代表了帕金森病的有前途的鼻内输送系统.
- 这种方法提高了生物可用性和鼻膜透率,提供了有效的治疗策略.
相关概念视频
Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
Bioavailability Enhancement: Drug Permeability Enhancement
176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
183
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
183
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
152
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
152


